Topic
fda-review
1 stories related to this topic, newest first.
foxbusiness.comfinance10 hrs ago
Trump Directs Federal Agencies to Accelerate Psychedelic Drug Research for Mental Health Treatments
President Donald Trump signed an executive order in April 2026 directing faster study of psychedelic compounds for conditions including PTSD and depression. The administration also issued priority review vouchers to three companies developing related therapies.